The Oct. 15, 2019 trial for Winston versus Monsanto in St. Louis will not begin as scheduled. A status conference has been scheduled for Feb. 2020 and a new trial date hasn't been set. Winston's is another trial contending Monsanto (now Bayer’s) Roundup causes cancer, specifically non-Hodgkin’s Lymphoma.
The lawsuit is one of several that was delayed as mediator Ken Feinberg tries to negotiate a settlement, according to Reuters.
“With the change in the trial schedule and no trial dates set through the rest of the year, the appeals of the three completed trials will be a significant focus of the litigation in the months ahead,” Bayer told Reuters.
Bayer says it will stand behind glyphosate.
“There has been no discussion of pulling this product,” says Liam Condon, president of Bayer Crop Science. “The scientific records for this product are so compelling from a safety and efficacy perspective. So, if you can’t defend this product there is no justification for any other product. There is no reasonable alternative—nothing is better or safer.”
Still, Bayer executives say the company will consider a settlement.
“There is mediation for some cases from northern California and the mediation is looking to see if there is a possibility for a settlement that is financially reasonable and represents finality [for current and future cases],” Condon says. “That’s what’s being assessed now and if we can find a path we will, if not, we’ll continue as normal.
“If you can’t justify glyphosate you couldn’t justify any crop protection product in the world—or even coffee—there are so many things IARC classifies as ‘potentially carcinogenic,’” he adds.